62 related articles for article (PubMed ID: 17971424)
1. Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.
Castagna MG; Brilli L; Pilli T; Montanaro A; Cipri C; Fioravanti C; Sestini F; Capezzone M; Pacini F
J Clin Endocrinol Metab; 2008 Jan; 93(1):76-81. PubMed ID: 17971424
[TBL] [Abstract][Full Text] [Related]
2. A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?
Persoon AC; Jager PL; Sluiter WJ; Plukker JT; Wolffenbuttel BH; Links TP
PLoS One; 2007 Aug; 2(8):e816. PubMed ID: 17726546
[TBL] [Abstract][Full Text] [Related]
3. One-year Thyroglobulin Levels as a Predictive Measure for Recurrence and Need for Continued Surveillance in Treated Differentiated Thyroid Cancer.
Herman AE; Argersinger DP; Maksutova M; Morgan T; Hughes DT
Endocr Pract; 2024 Feb; 30(2):89-94. PubMed ID: 37926368
[TBL] [Abstract][Full Text] [Related]
4. Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results.
Sandúa A; Macias M; Perdomo C; Galofre JC; Ferrer R; Alegre E; González Á
Adv Lab Med; 2020 Mar; 1(1):20190017. PubMed ID: 37362557
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer.
Pabst KM; Seifert R; Hirmas N; Broecker-Preuss M; Weber M; Peter Fendler W; Bartel T; Theurer S; Herrmann K; Görges R
Endocr Connect; 2023 Feb; 12(2):. PubMed ID: 36507775
[TBL] [Abstract][Full Text] [Related]
6. The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer.
Li S; Ren C; Gong Y; Ye F; Tang Y; Xu J; Guo C; Huang J
Front Endocrinol (Lausanne); 2022; 13():872527. PubMed ID: 35721746
[TBL] [Abstract][Full Text] [Related]
7. Biochemical Testing in Thyroid Disorders.
Esfandiari NH; Papaleontiou M
Endocrinol Metab Clin North Am; 2017 Sep; 46(3):631-648. PubMed ID: 28760230
[TBL] [Abstract][Full Text] [Related]
8. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with high thyroglobulin level following radioactive iodine ablation, measured 12 months after treatment for papillary thyroid carcinoma.
Kim EY; Hyun KH; Park YL; Park CH; Yun JS
Ann Surg Treat Res; 2017 Jan; 92(1):1-8. PubMed ID: 28090499
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit.
Kim M; Jeon MJ; Kim WG; Lee JJ; Ryu JS; Cho EJ; Ko DH; Lee W; Chun S; Min WK; Kim TY; Shong YK; Kim WB
Endocrinol Metab (Seoul); 2016 Sep; 31(3):462-468. PubMed ID: 27491718
[TBL] [Abstract][Full Text] [Related]
11. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C
Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060
[TBL] [Abstract][Full Text] [Related]
12. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
13. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Francis GL; Waguespack SG; Bauer AJ; Angelos P; Benvenga S; Cerutti JM; Dinauer CA; Hamilton J; Hay ID; Luster M; Parisi MT; Rachmiel M; Thompson GB; Yamashita S;
Thyroid; 2015 Jul; 25(7):716-59. PubMed ID: 25900731
[TBL] [Abstract][Full Text] [Related]
14. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
[TBL] [Abstract][Full Text] [Related]
15. Ability of the rhTSH stimulation test to predict relapse in patients with differentiated thyroid carcinoma, after long-term follow-up.
Marcelino M; Lopes AF; Madureira D; Ferreira TC; Limbert E; Leite V
Oncol Lett; 2015 Mar; 9(3):1281-1286. PubMed ID: 25663898
[TBL] [Abstract][Full Text] [Related]
16. Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy.
Kim KH; Kim MH; Lim YJ; Lee IS; Bae JS; Lim DJ; Baek KH; Lee JM; Kang MI; Cha BY
Int J Endocrinol; 2015; 2015():318916. PubMed ID: 25649811
[TBL] [Abstract][Full Text] [Related]
17. Radioactive iodine activities for postsurgical thyroid ablation: the lower the better.
Pacini F
Eur Thyroid J; 2013 Jan; 1(4):213-5. PubMed ID: 24783024
[No Abstract] [Full Text] [Related]
18. Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.
Han JM; Kim WB; Yim JH; Kim WG; Kim TY; Ryu JS; Gong G; Sung TY; Yoon JH; Hong SJ; Kim EY; Shong YK
Thyroid; 2012 Aug; 22(8):784-90. PubMed ID: 22780573
[TBL] [Abstract][Full Text] [Related]
19. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
[TBL] [Abstract][Full Text] [Related]
20. Advances in the follow-up of differentiated or medullary thyroid cancer.
Elisei R; Pinchera A
Nat Rev Endocrinol; 2012 Apr; 8(8):466-75. PubMed ID: 22473335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
